WALMART INC. for WALMART INC
What was lobbied
12 issue areas, each in the filer's own words, with who lobbied on it and where.
Immigration IMM
Discussions regarding comprehensive immigration reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| BELINDA GARZA HARTWIG | — |
| EDUARDO IVAN ZAPIEN | — |
Transportation TRA
H.R. 7, American Energy and Infrastructure Jobs Act S. 1813, MAP-21; Moving Ahead for Progress in the 21st Century
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM ROSS HEMPHILL | — |
| LAUREN ROBITAILLE | — |
| EDUARDO IVAN ZAPIEN | — |
Labor Issues/Antitrust/Workplace LBR
Discussions regarding implementation of certain provisions of the Employee Free Choice Act, including elimination of federally supervised private ballot union elections or mandatory arbitration for the first contracts, via the NLRB and concerns with NLRB decisions potentially impacting bargaining unit determinations, rulemakings by the NLRB and DOL, RIN 3142-AA08 and RIN 1215- AB79/RIN1245-AA03. Specialty healthcare case, 357 NLRB 83 H.R. 3094/S. 1843, the Workforce Democracy and Fairness Act S.J.Res 36, a joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the National Labor Relations Board relating to representation election procedures. Discussions regarding appropriations amendments on Specialty Healthcare preventing the NLRB from applying the case's precedent on other employers.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH (BEATTY) ROGERS | — |
| JAMES R. BAILEY | — |
| JANA BARRESI | — |
| BRUCE HARRIS | — |
| BELINDA GARZA HARTWIG | — |
| ADAM ROSS HEMPHILL | — |
| JASON HILL | — |
| LAUREN ROBITAILLE | — |
| SARAH THORN | — |
| EDUARDO IVAN ZAPIEN | — |
Health Issues HCR
Discussions regarding health information technology, health care reform principles, cost containment, generic drugs, and Medicare Part D, Pay for Delay S. 27, Preserve Access to Affordable Generics Act; S. 1882, Fair And Immediate Release of Generic Drugs Act H.R. 1063, The Smart Act: Employer Health Care Spending
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANA BARRESI | — |
| BRUCE HARRIS | — |
| JASON HILL | — |
| EDUARDO IVAN ZAPIEN | — |
Trade (domestic/foreign) TRD
Discussions regarding WTO negotiations Discussions regarding supply chain security issues Discussions regarding the Trans-Pacific Partnership negotiations and apparel trade Discussion of women's economic empowerment program Discussions regarding investments overseas Discussion regarding conflict minerals in the DRC Discussions regarding foreign assistance budget Discussions regarding customs reauthorization Discussions regarding APEC Discussions regarding exports, Sam's Club and small business Discussions related to FDI in India Discussions regarding Retailers and Entertainers Lacey Implementation and Enforcement Fairness Act (RELIEF Act), H.R. 3210
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH (BEATTY) ROGERS | — |
| JAMES R. BAILEY | — |
| JANA BARRESI | — |
| BELINDA GARZA HARTWIG | — |
| ADAM ROSS HEMPHILL | — |
| LAUREN ROBITAILLE | — |
| SARAH THORN | — |
| EDUARDO IVAN ZAPIEN | — |
Financial Institutions/Investments/Securities FIN
General discussions on federal reserve rule on interchange General discussions regarding financial services products Discussions regarding H.R.1081, Consumers Payment System Protection Act Discussions regarding DOJ Visa & Mastercard settlement Discussions regarding final rulemakings for the Durbin amendment Discussions related to Credit Card Act Implementation - PL 111-24 Discussions regarding CFPB
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH (BEATTY) ROGERS | — |
| JAMES R. BAILEY | — |
| JANA BARRESI | — |
| MARIO DE ARMAS | — |
| BRUCE HARRIS | — |
| BELINDA GARZA HARTWIG | — |
| JASON HILL | — |
| LAUREN ROBITAILLE | — |
| EDUARDO IVAN ZAPIEN | — |
Taxation/Internal Revenue Code TAX
Discussions regarding e-fairness taxation issues General corporate tax issues and interest in comprehensive tax reform S. 1549, American Jobs Creation Act S.1832, Marketplace Fairness Act H.R. 3179, Marketplace Equity Act of 2011 Discussions regarding Business Tax Extenders, R&D, and CFC Look through S. 1660, American Jobs Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH (BEATTY) ROGERS | — |
| JAMES R. BAILEY | — |
| JANA BARRESI | — |
| BRUCE HARRIS | — |
| BELINDA GARZA HARTWIG | — |
| ADAM ROSS HEMPHILL | — |
| JASON HILL | — |
| LAUREN ROBITAILLE | — |
| SARAH THORN | — |
| EDUARDO IVAN ZAPIEN | — |
Consumer Issues/Safety/Products CSP
Discussions regarding privacy issues related to e-commerce (H.R. 2577, S.1207) Discussions regarding customer insight studies
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH (BEATTY) ROGERS | — |
| JAMES R. BAILEY | — |
| JANA BARRESI | — |
| BRUCE HARRIS | — |
| BELINDA GARZA HARTWIG | — |
| ADAM ROSS HEMPHILL | — |
| LAUREN ROBITAILLE | — |
| SARAH THORN | — |
| EDUARDO IVAN ZAPIEN | — |
Energy/Nuclear ENG
Discussions regarding regulatory reform and waste disposal
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRUCE HARRIS | — |
| EDUARDO IVAN ZAPIEN | — |
Food Industry (safety, labeling, etc.) FOO
Discussions regarding Federal Nutrition programs from the consumer and retail perspective Discussions regarding food sourcing programs Discussions regarding hunger, nutrition policy, nutrition labeling and customer insights (no pending legislation) Discussions regarding access and affordability of healthy food, providing access to healthy food in food desert areas Discussions regarding pharmacy, health and wellness initiatives at Wal-mart S. 3240, the Agriculture Reform, Food and Jobs Act of 2012 Discussions regarding Walmart food sourcing and efforts to increase local sourcing
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH (BEATTY) ROGERS | — |
| JAMES R. BAILEY | — |
| EDUARDO IVAN ZAPIEN | — |
Pharmacy PHA
Discussions regarding generic drugs (no bill) S.3187, Food and Drug Administration Safety and Innovation Act S.Amdt. 2151 to S.3187, to amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON HILL | — |
| EDUARDO IVAN ZAPIEN | — |
Homeland Security HOM
Discussions related to cargo security, C-TPAT, emergency preparedness and readiness issues, and port security. Discussions regarding cybersecurity, data security and privacy issues (S.21, S. 1207) S. 799, Commercial Privacy Bill of Rights Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM ROSS HEMPHILL | — |
| LAUREN ROBITAILLE | — |
| EDUARDO IVAN ZAPIEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.